Kerrie Brady

Kerrie Brady

Company: OcuTerra

Job title: Chief Executive Officer


Panel Discussion: The Race to Market Share: Is the Answer Ending the Burden of Monthly Treatments? 4:10 pm

Longer-term VEGF inhibition is needed to combat the burden of monthly treatments. This panel will explore extended-duration therapeutic possibilities with a focus on the anti-VEGF pathway to reduce the number of times the patient has to visit the clinic and the side effects of the therapeutic. It will also touch on the question – is…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.